🔗 Share this article

Treasury head Rachel Reeves has revealed she is planning "specific measures to deal with household expense challenges" in next month's financial statement.

In comments to media outlets, she stated that lowering price rises is a joint task of both the administration and the Bank of England.

The UK's price growth is forecast to be the highest among the Group of Seven advanced economies this year and the following year.

Potential Energy Cost Measures

Reports indicate the government could take action to bring down energy bills, such as by slashing the present 5% rate of VAT charged on energy.

An additional approach is to reduce some of the policy costs presently included in household expenses.

Budgetary Limitations and Analyst Expectations

The government will obtain the latest report from the official forecaster, the OBR, on Monday, which will reveal how much space there is for these measures.

The consensus from the majority of analysts is that the Chancellor will have to announce tax increases or budget cuts in order to adhere to her voluntary borrowing rules.

Earlier on Thursday, estimates suggested there was a twenty-two billion pound gap for the Treasury chief to fill, which is at the lower end of projections.

"It is a joint task between the Bank of England and the government to continue tackling some of the drivers of price increases," Reeves stated to reporters in the US capital, at the yearly gatherings of the International Monetary Fund and global financial institution.

Revenue Commitments and International Concerns

While much of the focus has been on expected tax increases, the Treasury chief said the latest figures from the OBR had not altered her pledge to campaign commitments not to increase tax levels on earnings tax, VAT or National Insurance.

She attributed an "uncertain world" with increasing international and commercial concerns for the Budget tax moves, probably to be directed on those "with the broadest shoulders."

International Economic Disputes

Referring to concerns about the UK's economic relations with the Asian nation she said: "Our national security invariably take priority."

Recent declaration by Chinese authorities to increase export controls on critical minerals and other materials that are crucial for high-technology production led American leader Donald Trump to threaten an extra 100% import tax on goods from the Asian country, increasing the risk of an full-scale trade war between the two global powers.

The American finance chief described the Chinese move "economic coercion" and "a international production control attempt."

Questioned on considering the American proposal to join its dispute with China, the Chancellor said she was "extremely troubled" by China's measures and called on the Chinese government "not to put up barriers and limit trade."

She said the move was "bad for the world economy and creates further challenges."

"In my view there are sectors where we should confront China, but there are also significant chances to export to China's economy, including financial services and other areas of the economy. We've got to get that equilibrium right."

The chancellor also affirmed she was working with international partners "regarding our own critical minerals strategy, so that we are more independent."

Health Service Drug Costs and Funding

The Chancellor also admitted that the cost the National Health Service spends on medicines could go up as a result of current discussions with the Trump administration and its drugs companies, in return for lower tariffs and investment.

A number of the biggest global pharmaceutical manufacturers have said in recent statements that they are either pausing or abandoning operations in the UK, with some attributing the low prices they are receiving.

Recently, the government science advisor said the price the health service pays for medicines would have to rise to stop companies and pharmaceutical investment departing from the United Kingdom.

Reeves informed media: "It has been observed as a result of the payment system, that clinical trials, innovative medicines have not been available in the UK in the manner that they are in other continental states."

"The objective is to make sure that people receiving care from the NHS are can access the top critical drugs in the globe. And so we are examining this situation, and... looking to obtain additional funding into the UK."